Experience of a vasopressin receptor antagonist, tolvaptan, under the unique indication in Japanese heart failure patients

K. Kinugawa*, T. Imamura, I. Komuro

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations
Original languageEnglish
Pages (from-to)449-451
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume94
Issue number4
DOIs
StatePublished - 2013/10

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this